Donepezil modulates the endogenous immune response: implications for Alzheimer's disease.

Saved in:
Bibliographic Details
Title: Donepezil modulates the endogenous immune response: implications for Alzheimer's disease.
Authors: Conti, Elisa, Tremolizzo, Lucio, Santarone, Marta Elena, Tironi, Marco, Radice, Isabella, Zoia, Chiara Paola, Aliprandi, Angelo, Salmaggi, Andrea, Dominici, Roberto, Casati, Marco, Appollonio, Ildebrando, Ferrarese, Carlo
Source: Human Psychopharmacology: Clinical & Experimental. Jul2016, Vol. 31 Issue 4, p296-303. 8p.
Subjects: Donepezil, Alzheimer's disease treatment, T helper cells, Immunoprecipitation, Cholinergic receptor research, Therapeutics
Abstract: Objective Donepezil (DNPZ) is a drug commonly used for Alzheimer's disease (AD) that may favour a T helper 2 phenotype leading to increased naturally occurring auto-antibodies (NAb) against beta-amyloid (Aβ). We hypothesized the involvement of the cholinergic receptors [α7-nicotnic acetylcholine receptor (α7nAChR)] expressed on peripheral blood mononuclear cells (PBMC). Methods Fifty patients with mild-to-moderate AD, DNPZ treated (DNPZ+, n = 25) or not (DNPZ−, n = 25), and 25 matched controls were enrolled and PBMC extracted for both in vitro cultures, and real-time polymerase chain reaction and chromatin immunoprecipitation assay. Plasma samples were also obtained for Aβ and NAb determination. Results Donepezil increased in vitro the expression of the transcription factor GATA binding protein 3 (GATA3) through α7nAChR, because prevented by the specific antagonist methyllycaconitine. Ex vivo PBMC α7nAChR mRNA expression was increased in both AD groups, while GATA3 expression was not. A significant increase in the GATA3/interleukin 5 promoter association was found in DNPZ+ patients. Finally, DNPZ+ patients showed both significantly higher plasma levels of anti-Aβ NAb with respect to DNPZ− patients and Aβ 1-42 with respect to normal controls. Conclusions Donepezil might modulate a T helper 2 bias via α7nAChR leading to increased expression of NAb. Further studies on the role of the modulation of the immune response against Aβ may pave the way to innovative therapeutic strategies for AD. Copyright © 2016 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
Copyright of Human Psychopharmacology: Clinical & Experimental is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Psychology and Behavioral Sciences Collection
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: pbh
DbLabel: Psychology and Behavioral Sciences Collection
An: 116620148
AccessLevel: 6
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Donepezil modulates the endogenous immune response: implications for Alzheimer's disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Conti%2C+Elisa%22">Conti, Elisa</searchLink><br /><searchLink fieldCode="AR" term="%22Tremolizzo%2C+Lucio%22">Tremolizzo, Lucio</searchLink><br /><searchLink fieldCode="AR" term="%22Santarone%2C+Marta+Elena%22">Santarone, Marta Elena</searchLink><br /><searchLink fieldCode="AR" term="%22Tironi%2C+Marco%22">Tironi, Marco</searchLink><br /><searchLink fieldCode="AR" term="%22Radice%2C+Isabella%22">Radice, Isabella</searchLink><br /><searchLink fieldCode="AR" term="%22Zoia%2C+Chiara+Paola%22">Zoia, Chiara Paola</searchLink><br /><searchLink fieldCode="AR" term="%22Aliprandi%2C+Angelo%22">Aliprandi, Angelo</searchLink><br /><searchLink fieldCode="AR" term="%22Salmaggi%2C+Andrea%22">Salmaggi, Andrea</searchLink><br /><searchLink fieldCode="AR" term="%22Dominici%2C+Roberto%22">Dominici, Roberto</searchLink><br /><searchLink fieldCode="AR" term="%22Casati%2C+Marco%22">Casati, Marco</searchLink><br /><searchLink fieldCode="AR" term="%22Appollonio%2C+Ildebrando%22">Appollonio, Ildebrando</searchLink><br /><searchLink fieldCode="AR" term="%22Ferrarese%2C+Carlo%22">Ferrarese, Carlo</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Human+Psychopharmacology%3A+Clinical+%26+Experimental%22">Human Psychopharmacology: Clinical & Experimental</searchLink>. Jul2016, Vol. 31 Issue 4, p296-303. 8p.
– Name: Subject
  Label: Subjects
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22Donepezil%22">Donepezil</searchLink><br /><searchLink fieldCode="DE" term="%22Alzheimer's+disease+treatment%22">Alzheimer's disease treatment</searchLink><br /><searchLink fieldCode="DE" term="%22T+helper+cells%22">T helper cells</searchLink><br /><searchLink fieldCode="DE" term="%22Immunoprecipitation%22">Immunoprecipitation</searchLink><br /><searchLink fieldCode="DE" term="%22Cholinergic+receptor+research%22">Cholinergic receptor research</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%22">Therapeutics</searchLink>
– Name: Abstract
  Label: Abstract
  Group: Ab
  Data: Objective Donepezil (DNPZ) is a drug commonly used for Alzheimer's disease (AD) that may favour a T helper 2 phenotype leading to increased naturally occurring auto-antibodies (NAb) against beta-amyloid (Aβ). We hypothesized the involvement of the cholinergic receptors [α7-nicotnic acetylcholine receptor (α7nAChR)] expressed on peripheral blood mononuclear cells (PBMC). Methods Fifty patients with mild-to-moderate AD, DNPZ treated (DNPZ+, n = 25) or not (DNPZ−, n = 25), and 25 matched controls were enrolled and PBMC extracted for both in vitro cultures, and real-time polymerase chain reaction and chromatin immunoprecipitation assay. Plasma samples were also obtained for Aβ and NAb determination. Results Donepezil increased in vitro the expression of the transcription factor GATA binding protein 3 (GATA3) through α7nAChR, because prevented by the specific antagonist methyllycaconitine. Ex vivo PBMC α7nAChR mRNA expression was increased in both AD groups, while GATA3 expression was not. A significant increase in the GATA3/interleukin 5 promoter association was found in DNPZ+ patients. Finally, DNPZ+ patients showed both significantly higher plasma levels of anti-Aβ NAb with respect to DNPZ− patients and Aβ 1-42 with respect to normal controls. Conclusions Donepezil might modulate a T helper 2 bias via α7nAChR leading to increased expression of NAb. Further studies on the role of the modulation of the immune response against Aβ may pave the way to innovative therapeutic strategies for AD. Copyright © 2016 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]
– Name: AbstractSuppliedCopyright
  Label:
  Group: Ab
  Data: <i>Copyright of Human Psychopharmacology: Clinical & Experimental is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.)
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=pbh&AN=116620148
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hup.2538
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 8
        StartPage: 296
    Subjects:
      – SubjectFull: Donepezil
        Type: general
      – SubjectFull: Alzheimer's disease treatment
        Type: general
      – SubjectFull: T helper cells
        Type: general
      – SubjectFull: Immunoprecipitation
        Type: general
      – SubjectFull: Cholinergic receptor research
        Type: general
      – SubjectFull: Therapeutics
        Type: general
    Titles:
      – TitleFull: Donepezil modulates the endogenous immune response: implications for Alzheimer's disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Conti, Elisa
      – PersonEntity:
          Name:
            NameFull: Tremolizzo, Lucio
      – PersonEntity:
          Name:
            NameFull: Santarone, Marta Elena
      – PersonEntity:
          Name:
            NameFull: Tironi, Marco
      – PersonEntity:
          Name:
            NameFull: Radice, Isabella
      – PersonEntity:
          Name:
            NameFull: Zoia, Chiara Paola
      – PersonEntity:
          Name:
            NameFull: Aliprandi, Angelo
      – PersonEntity:
          Name:
            NameFull: Salmaggi, Andrea
      – PersonEntity:
          Name:
            NameFull: Dominici, Roberto
      – PersonEntity:
          Name:
            NameFull: Casati, Marco
      – PersonEntity:
          Name:
            NameFull: Appollonio, Ildebrando
      – PersonEntity:
          Name:
            NameFull: Ferrarese, Carlo
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: Jul2016
              Type: published
              Y: 2016
          Identifiers:
            – Type: issn-print
              Value: 08856222
          Numbering:
            – Type: volume
              Value: 31
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Human Psychopharmacology: Clinical & Experimental
              Type: main
ResultId 1